Digest Martin-Vertedor2016
Digest Martin-Vertedor2016
Digest Martin-Vertedor2016
Daniel Martín-Vertedor,1* María Garrido,2 José Antonio Pariente,2 Javier Espino2 and
Jonathan Delgado-Adámez1
1
Technological Institute of Food and Agriculture (INTAEX), Extremadura Government, Avda. Adolfo Suárez s/n, 06007, Badajoz,
Spain
2
Department of Physiology, Neuroimmunophysiology, and Chrononutrition Research Group, Faculty of Science, University of
Extremadura, Avda. Elvas s/n, 06006, Badajoz, Spain
Olive leaves are an important low-cost source of bioactive compounds. The present study aimed to examine the
effect of in vitro digestibility of an olive leaf aqueous extract so as to prove the availability of its phenolic com-
pounds as well as its antioxidant, antimicrobial, and anticancer activity after a simulated digestion process. The
total phenolic content was significantly higher in the pure lyophilized extract. Phenolic compounds, however,
decreased by 60% and 90% in simulated gastric fluid (SGF) and simulated intestinal fluid (SIF), respectively.
Regarding antioxidant activity, it was reduced by 10% and 50% after gastric and intestinal digestion, respec-
tively; despite this fact, high antioxidant capacity was found in both SGF and SIF. Moreover, the olive leaf extract
showed an unusual combined antimicrobial action at low concentration, which suggested their great potential as
nutraceuticals, particularly as a source of phenolic compounds. Finally, olive leaf extracts produced a general
dose-dependent cytotoxic effect against U937 cells. To sum up, these findings suggest that the olive leaf aqueous
extract maintains its beneficial properties after a simulated digestion process, and therefore its regular consump-
tion could be helpful in the management and the prevention of oxidative stress-related chronic disease, bacterial
infection, or even cancer. Copyright © 2016 John Wiley & Sons, Ltd.
Keywords: olive leaf; phenolic compounds; antibacterial activity; antifungal activity; anticancer activity.
investigations of the handling of phenolics by the gastro- from leaves with ultrapure water (1:10 w/v) for 3 h at
intestinal tract and their subsequent absorption and 60–65 °C, and the extract was filtered and centrifuged
metabolism (Karakaya, 2004). at 21,036 ×g to remove solid particles (Delgado-Adámez
Currently, research in the field has focused the atten- et al., 2014).
tion on understanding the mechanisms of release of cer-
tain food compounds, especially those considered
beneficial for human health. However, it is crucial to Stabilization of aqueous extract. The olive leaf extracts
develop accurate models of digestion that simulate the were stored at 80 °C until they were freeze-dried in a
set of reactions that occur in the interior of the gastroin- lyophilizer (Virtis Company, Mod. Génesis 25 LL,
testinal tract in order to verify the potential bioavailabil- Hücoa-Herlos). The dry extracts obtained were kept away
ity and effectiveness of these products. In vivo methods from the light (at room temperature) in amber-colored
are more accurate and appropriate, but they are slow glass bottles until further analysis.
and often quite expensive. This is why researchers tend
to develop in vitro digestion techniques that pose a
quicker and cheaper alternative, despite the fact that
in vitro methods do not manage to achieve similar levels Simulated gastrointestinal digestion. To study the
of accuracy compared to the in vivo ones because of the behavior of the olive leaf extract during digestion, con-
inherent complexity of the process. Thus, a series of trol (ultrapure water) and olive leaf extract were sub-
in vitro digestion models have been developed to assess jected to an in vitro assay following the method
structural changes, bioavailability, and digestibility of described by Calvo et al. (2012). The in vitro digestion
foods, indicating that in vitro digestion systems are com- was carried out in three phases. First, samples were
mon and useful tools for analyses of foods and drugs exposed to an oral fluid which contained 1 mL of human
(Hur et al., 2011). saliva g1 of extract. After that, they were mixed at slow
To further support the functional value of olive leaf speed using an Omni Mixer Homogenizer (Ivan Sorvall,
extract and increase the value of the by-products gener- Inc., Norwalk, Conn. USA) during 20 s. A warm bath
ated in the olive industry, the general objective of this was used to maintain the temperature around 37 °C.
research was to assess the antioxidant, antimicrobial, Second, the mix was exposed to simulated gastric fluid
and anticancer effects of olive leaf aqueous extract (SGF) containing pepsin and sodium chloride at low
before and after in vitro gastrointestinal process. pH value. Finally, an intestinal digestion was simulated
by exposing gastric digestion elements to a simulated
intestinal fluid (SIF) containing pancreatin, lipase, as
well as cholic and deoxycholic acids in PBS buffer.
The SGF was prepared according to the United States
MATERIALS AND METHODS Pharmacopeia method (The United States Pharmacopeial
Convention, Inc, 2000) and contained 0.2-g pepsin and
Plant materials. The study was carried out in the Tech- 0.125-g sodium chloride in deionized water to give a final
nological Institute of Food and Agriculture of Extrema- volume of 62.5 mL at pH 1.5.
dura (INTAEX). The olive leaves were picked up from The mix of olive leaf extract (1 g) and saliva was
the experimental olive (Olea europaea L.) orchard added to 3.6 mL of SGF and the final mixture (pH 2.2)
maintained by the Researcher Center ‘Finca La was stirred for 20 min at 37 °C in the digester (K-349;
Orden-Valdesequera’ (Badajoz, Spain) within the limits Buchi, Flawil, Switzerland). After that, pH was adjusted
of the olive-growing area ‘Tierra de Barros’. Samplings to 6.5 with NaOH to inactivate pepsin. The SIF was pre-
of the olive leaves of ‘Arbequina’ cultivar were carried pared in 0.1 M PBS buffer (100 mL, pH 3.4) containing
out in the morning, taking samples randomly, in perfect 20-mg pancreatin, 5-mg lipase, 10 mM cholic acid, and
sanitary conditions. Specifically, 500 g of olive leaves 10 mM deoxycholic acid (Lee et al., 2003). Then,
was taken from different parts of the central area of 3.6 mL of SIF was added to the resulting product of
the olive tree in three times. The samples were collected the gastric digestion, adjusting the pH to a final value
at spotted stages of maturation, using the subjective of 6.5. The mixture was stirred for 20 min at 37 °C to
evaluation of color of the skin and flesh. After harvest- complete the intestinal digestion.
ing, all samples were immediately transported to the After each digestion step (gastric and intestinal), the
INTAEX laboratory, using ventilated storage trays to digestion mixtures were centrifuged at 21,036 ×g for
avoid compositional changes. The olive leaves were 10 min at 4 °C to remove solid particles. Finally, they
vacuum-packed (Gustav Müller VS 100, Germany) in were quickly stored in amber-colored glass bottles at
plastic bags and stored at 80 °C until further use. 80 °C until further analysis.
Extraction of bioactive compounds. Olive leaves used in Chemicals and instruments. HPLC analysis was per-
this study were removed from leaders by hand. Olive formed using an Agilent Technologies series 1100
leaves were partially dried in a conventional oven (Agilent Technologies S.L., Madrid, Spain) system
(model 210, Selecta® P, Spain) for 12 min at 120 °C to equipped with an automatic injector and a diode array
obtain the most suitable material to perform the subse- UV detector. HPLC mobile phase was provided by
quent extraction. Samples were mixed two or three Calbiochem (USA and Canada). Folin-Ciocalteau re-
times while they were in the oven to facilitate drying. agent, caffeic acid, and sodium carbonate were procured
Dried samples were ground in a domestic knife mill from Panreac (Barcelona, Spain). MTT (3-[4,5-dimethyl-
and were sieved to select particles between 0.5 and thiazol-2-yl]-2,5 diphenyl tetrazolium bromide), DMSO,
3.0 mm. Finally, bioactive compounds were extracted and 6-hidroxy-2,5,7,8-tetramethyl-chroman-2-carboxylic
Copyright © 2016 John Wiley & Sons, Ltd. Phytother. Res. (2016)
POTENTIAL HEALTH BENEFITS OF OLIVE LEAF EXTRACT
acid (Trolox) were acquired from Sigma-Aldrich (CECT) of Valencia University. The bacterial strain
(Madrid, Spain), whereas 2,2′azobis-(3-ethylbenzothiazo- used in the assay of the antimicrobial activity of the
line-6-sulfonic acid) (ABTS) was obtained from Fluka extracts was Escherichia coli 45.
Chemicals (Madrid, Spain). All enzymes for in vitro diges-
tion experiments were purchased from Sigma-Aldrich. Determination of antimicrobial activity. The antimi-
All chemicals for the digestive fluids were obtained from crobial activity was studied following the procedure pre-
Merck (Madrid, Spain). An UV–Vis spectrophotometer viously established by Delgado-Adámez et al. (2012a).
model HP8453 (Agilent, Madrid, Spain) was used for These analyses were carried out in both the olive leaf
antioxidant potential and total polyphenol content analy- dry extract, and the extracts digested in the simulated
ses. An automatic microplate reader (Infinite M200; model (gastric and intestinal). The extracts were first
Tecan Austria GmbH, Groedig, Austria) was utilized solved in water and then diluted to the highest concen-
for the cytotoxicity assay. tration (0.1% v/v) to be tested. Afterwards, serial dilu-
tions were made in a concentration range from 0.1%
to 0.001% (v/v). The target microorganism was cultured
Individual phenolic compound determination. The in Mueller-Hinton broth (MHB) at 37 °C for 24 h. After
individual phenolic compounds was analyzed in both that, the suspensions were diluted with 0.5 McFarland
the olive leaf extract and the extract digested in the sim- standard turbidity and diluted again (1/1000 ratio) in
ulated model (gastric and intestinal) following the MHB. It was added 180 μL of MHB containing diluted
method proposed by González-Gómez et al. (2009) with bacteria (~105 Colony-Forming Units (CFU) mL1)
some minor modifications. Chromatographic separation and 20 μL of the different solutions of the extracts per
was accomplished with a Phenomenex C18 HPLC well in 96-well microtiter plates. A positive control (con-
column (150 mm × 4.6 mm, 5 μm) heated to 35 °C. The taining inoculums but no extracts) and negative control
mobile phase used for the separation was composed of (containing extracts but no inoculums) were included
aqueous TFA 0.1% (A) and acetonitrile (B) in gradient on each microplate to verify any change in absorbance
mode set as follows: initial conditions, 10% of B; from 0 of the olive leaf extract. The contents of the wells were
to 3 min, 10% of B; from 3 to 15 min, 15% of B; from 15 mixed and the microplates were incubated at 37 °C for
to 20 min the composition was kept constantly at 15% of 24 h under aerophilic conditions. Absorbances at
B; from 20 to 25 min, 18% of B; and from 25 to 40 min, 450 nm were measured at 0 and 24 h in a plate reader.
30% of B. A period of 5 min was necessary for column Turbidity readings were related to bacterial growth.
equilibration. The flow was fixed at 0.500 mL/min for The inhibitory effect was calculated using the following
all the experiments. The injected volume was 5 μL. formula:
Chromatographic data processing was performed
ΔAbsReference - ΔAbsAssay
using Agilent ChemStation software, and the quantifica- %Inhibition ¼ 100
tion was done by external standard method. Phenolic ΔAbsReference
compound quantification was achieved by the absor- where:ΔAbsReference is the increase in absorbance of
bance recorded in the chromatograms relative to exter- control sample.ΔAbsAssay is the increase in absorbance
nal standards, with detection at 280 nm for oleuropein of test sample.
and flavanol, at 320 nm for phenolic acids and
vesbascoside, at 350 nm for flavonoids, and at 360 nm
for flavonols. Luteolin derivatives were quantified as
Anticancer activity assay
milligrams of luteolin 7-O-glucoside, flavanol was quan-
tified in milligrams of epicatechin, and flavonols were
measured in milligrams of quercetin-3-O-rutinoside. Cell culture. Human histiocytic leukemia (U937) cell
The other compounds were quantified as themselves. line (ECACC No. 85011440) was grown in RPMI 1640
medium (Lonza, Barcelona, Spain) supplemented with
2 mM L-glutamine, 10% heat-inactivated fetal bovine
serum, 100 U/mL penicillin and 100 μg/mL streptomy-
Antioxidant activity assay. The capacity of radical scav- cin. Cells were cultured in a humidified atmosphere con-
enging of both the olive leaf dry extract and the extract taining 5% CO2 at 37 °C. Given that previous works has
digested in the simulated model (gastric and intestinal) proven the efficiency of different olive leaf extracts
was assessed by the ABTS• + method (Cano et al., against leukemia cells (Abaza et al., 2007; Fares et al.,
2000). Briefly, 1 mL of the radical cation ABTS was 2011; Samet et al., 2014), we used U937 cells to study
placed in a spectrophotometric cuvette, and 20 μL of whether the olive leave extracts maintained their anti-
the phenolic extract was added. The initial absorbance cancer potential after a simulated digestion.
value at 730 nm was then compared with the
absorbance obtained after 20 min of reaction. The Cytotoxicity assay. The cytotoxic effects of the olive
results were expressed as Trolox antioxidant equivalents leaf extract on leukemic U937 cell line were studied by
(TAE) that were expressed as mmol Trolox kg1 the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl
extract. The calibration curve was done using different tetrazolium bromide) assay. The cells were seeded at a
Trolox concentrations. density of 5 × 104 cells/well in 24-well plates. The olive
leaf dry extract (1 g) was dissolved in 9 ml distilled
H2O and then serially diluted in a concentration range
Antimicrobial activity assay from 0.1% to 0.001% (v/v). The aqueous extract
digested in the simulated model (both gastric and intes-
Bacterial strains. Bacterial cultures used in this study tinal digestion) was also serially diluted in a concentra-
were obtained from the Spanish type culture collection tion range from 0.1% to 0.001% (v/v). Five microliters
Copyright © 2016 John Wiley & Sons, Ltd. Phytother. Res. (2016)
D. MARTÍN-VERTEDOR ET AL.
Table 1. Composition of the individual phenolic compounds and antioxidant activity obtained in the olive leaf aqueous extract and after
gastric and intestinal digestion in vitro
Phenolic acids
Gallic acid 1.73 ± 0.14 nd nd
Vanillin 0.47 ± 0.15 nd nd
p-Cumaric acid 0.81 ± 0.16 nd nd
Ferulic acid nq nq nq
Chlorogenic acid 30.72 ± 0.82 nd nd
b a
Caffeic acid 201.5 ± 21.2 18.7 ± 0.19 nd
Phenolic alcohol
c b a
Hydroxytyrosol 10 924.7 ± 541.6 3195.1 ± 457.6 1124.4 ± 142.8
c b a
Tyrosol 1681.2 ± 111.4 369.8 ± 71.6 170.2 ± 11.0
Secoiridoid derivatives
c b a
Oleuropein 22 541.8 ± 1057.6 4050.6 ± 122.5 1447.9 ± 155.5
Flavonoids
c b a
Luteolin 7-o-glucoside 3741.9 ± 120.1 698.7 ± 44.8 268.9 ± 17.6
c b a
Apigenin 7-o-glucoside 2147.1 ± 124.9 587.4 ± 11.1 257.4 ± 19.5
c b a
Rutin 357.4 ± 14.7 50.7 ± 11.6 25.7 ± 8.8
Hidrocinamic derivatives
c b a
Verbascoside 914.4 ± 20.7 196.4 ± 17.1 79.6 ± 14.6
Lignans
Pinoresinol nd nd nd
Acetoxypinoresinol nd nd nd
Flavanol
Epicatechin 21.73 ± 0.37 nd nd
Flavonols
Quercetin-3-O-rutinoside 14.89 ± 0.67 nd nd
b a
Quercetin-3-O-galactoside 30.57 ± 1.55 11.7 ± 8.6 nd
Kaempferol 5.58 ± 0.42 nd nd
c b a
Antioxidant activity (mmol Trolox l-1 extract) 15.6 ± 2.01 10.3 ± 0.15 8.4 ± 0.01
Results are expressed as mean ± SEM of three sample replicates. Different small letters in the same row indicate significant statistical differ-
ences (Tukey’s test, p < 0.05) among treatments. nd: not detected; nq: not quantified.
Copyright © 2016 John Wiley & Sons, Ltd. Phytother. Res. (2016)
POTENTIAL HEALTH BENEFITS OF OLIVE LEAF EXTRACT
its antioxidant activity, might contribute to its antimicro- and/or cell killing abilities of different olive leaf extracts
bial properties as well (Sudjana et al., 2009; Lee and against leukemia cells (Abaza et al., 2007; Fares et al.,
Lee, 2010). In particular, oleuropein, has exhibited anti- 2011; Samet et al., 2014), none of them has proved
bacterial activity against a wide variety of Gram-positive whether the extracts maintained their anticancer prop-
and Gram-negative human pathogenetic bacterial erties once they entered the gastrointestinal tract.
strains (Pereira et al., 2007a; Sudjana et al., 2009), anti- Therefore, olive leaf extracts warrant further investiga-
fungal properties (Aziz et al., 1998), as well as antiviral tion into their potential antileukemic benefits.
actions mostly against enveloped viruses (Ma et al., Overall, our results suggested that the olive leaf aque-
2001; Micol et al., 2005). Similarly, chlorogenic acid has ous extract, which possessed high content in phenolic
been shown to have strong antimicrobial activity compounds, could be absorbed by the gastrointestinal
(Davidson and Branen, 1981), and is usually present in tract, and its regular consumption may be helpful in
olive leaf and drupe extracts (Brahmi et al., 2013). The the management and the prevention of oxidative
active portion of chlorogenic acid, according to stress-related chronic diseases, bacterial infection, or
Grodzinska-Zachwieja and Kahl (1966), is caffeic acid, cancer. In fact, even after simulated digestion, the olive
a hydroxycinnamic acid. Several hydroxycinnamic acid leaf extract depicted in vitro antioxidant, antimicrobial,
derivatives have been found to have antimicrobial and antitumor activities.
effects against several microorganisms, including E. coli
(Lee and Lee, 2010). During the digestion these com-
pounds are reduced, which may be directly correlated
with the lower antimicrobial activity found with respect Acknowledgements
to that obtained in aqueous extracts. Anyway, our find- This work has been financed by European Regional Development
ings demonstrated that the use of olive leaves as Funds (ERDF). This study has been carried out with financial sup-
nutraceuticals may diminish the risk of E. coli infections, port from Government of Extremadura (project 6/12). J. Espino
particularly in the gastric and intestinal tract as observed and M. Garrido hold a research post-doctoral fellowship from
with 1:10 and 1:100 dilutions, which is probably because Government of Extremadura (jointly financed by the European
of the protective actions provided by its phenolic Regional Development Fund (ERDF); ref. PO14011 and PO14013,
compounds. respectively). The authors wish to thank to the Research Centre
In relation to the anticancer assay, our findings sug- ‘Finca la Orden-Valdesequera’ by the products of the field experi-
ment cultivars.
gested that the digested olive leaf extract could preserve
its anticancer potential against human histiocytic
leukemia U937 cells, as observed after the in vitro diges-
tion processing, thereby indicating that the extract may Conflict of Interest
be able to act at systemic level. Despite the fact that pre-
vious research has already tested the anti-proliferative The authors have no conflict of interest to declare.
REFERENCES
Abaza L, Talorete TP, Yamada P, Kurita Y, Zarrouk M, Isoda H. De Marino S, Festa C, Zollo F, et al. 2014. Antioxidant activity and
2007. Induction of growth inhibition and differentiation of chemical components as potential anticancer agents in the
human leukemia HL-60 cells by a Tunisian gerboui olive leaf olive leaf (Olea europaea L. cv Leccino) decoction. Anticancer
extract. Biosci Biotechnol Biochem 71: 1306–1312. Agents Med Chem 14(10): 1376–1385.
Aziz NH, Farag SE, Mousa LAA, Abo-Zaid MA. 1998. Comparative Delgado-Adámez J, Fernández-León MF, Velardo-Micharet B,
antibacterial and antifungal effects of some phenolic com- González-Gómez D. 2012b. In vitro assays of the antibacterial
pounds. Microbios 93: 43–54. and antioxidant activity of aqueous leaf extracts from different
Borchers AT, Keen CL, Gerstiwin ME. 2004. Mushrooms, tumors, Prunus salicina Lindl. cultivars. Food Chem Toxicol 50:
and immunity: an update. Exp Biol Med 229: 393–406. 2481–2486.
Brahmi F, Mechri B, Dhibi M, Hammami M. 2013. Variations in phe- Delgado-Adámez J, Franco MN, Ayuso MC, Martín-Vertedor D.
nolic compounds and antiradical scavenging activity of Olea 2014. Oxidative stability, phenolic compounds and antioxi-
europaea leaves and fruits extracts collected in two different dant potential of a virgin olive oil enriched with natural bioac-
seasons. Ind Crops Prod 49: 256–264. tive compounds. J Oleo Sci 63: 55–65.
Briante R, Patumi M, Terenziani S, Bismuto E, Febbraio F, Nucci R. Delgado-Adámez J, Gamero E, Valdés E, González-Gómez D.
2002. Olea europaea L. leaf extract and derivatives: antioxi- 2012a. In vitro estimation of the antibacterial activity and
dant properties. J Agric Food Chem 50: 4934–4940. antioxidant capacity of aqueous extracts from grape-seeds
Calvo P, Castaño AL, Lozano M, González-Gómez D. 2012. Influ- (Vitis vinifera L.) Food Control 24: 136–141.
ence of the microencapsulation on the quality parameters EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and
and shelf-life of extra-virgin olive oil encapsulated in the pres- Allergies). 2014. Scientific Opinion on the substantiation of a
ence of BHT and different capsule wall components. Food Res health claim related to olive (Olea europaea L.) leaf water
Int 45: 256–261. extract and increase in glucose tolerance pursuant to Article
Cano A, Acosta M, Arnao MB. 2000. A method to measure antiox- 13(5) of Regulation (EC) No 1924/2006. EFSA Journal
idant activity in organic media: application to lipophilic vita- 12(5): 3655 10 pp.
mins. Redox Rep 5: 365–370. El Sedef N, Karakaya S. 2009. Olive tree (Olea europaea) leaves:
Carrasco-Pancorbo A, Cerretani L, Bendini A, et al. 2005. Evalua- potential beneficial effects on human health. Nutr Rev
tion of the antioxidante capacity of individual phenolic com- 67(11): 632–638.
pounds in virgin olive oil. J Agric Food Chem 53: 8918–8925. Fakhraei N, Abdolghaffari AH, Delfan B, et al. 2014. Protective
Covas MI. 2008. Bioactive effects of olive oil phenolic compounds effect of hydroalcoholic olive leaf extract on experimental
in humans: reduction of heart disease factors and oxidative model of colitis in rat: involvement of nitrergic and opioidergic
damage. Inflammopharmacology 16: 1–3. systems. Phytother Res 28(9): 1367–1373.
Davidson PM, Branen AL. 1981. Antimicrobial activity of Fares R, Bazzi S, Baydoun SE, Abdel-Massih RM. 2011. The anti-
non-halogenated phenolic compounds. J Food Prot 44: oxidant and anti-proliferative activity of the Lebanese Olea
623–632. europaea extract. Plant Foods Hum Nutr 66: 58–63.
Copyright © 2016 John Wiley & Sons, Ltd. Phytother. Res. (2016)
D. MARTÍN-VERTEDOR ET AL.
Fuentes M, De Miguel C, Ranalli A, et al. 2015. Chemical composi- Oliveira I, Sousa A, Morais JS, et al. 2008. Chemical composition,
tion and sensory evaluation of virgin olive oils from “Morisca” and antioxidant and antimicrobial activities of three hazelnut
and “Carrasqueña” olive varieties. Grasas y Aceites 66(1): (Corylus avellana L.) cultivars. Food Chem Toxicol 46:
e061. 1801–1807.
Giugliano D, Esposito K. 2005. Mediterranean diet and cardiovas- Olmez E, Vural K, Gok S, et al. 2015. Olive leaf extract improves
cular health. Ann N Y Acad Sci 1056: 253–260. the atherogenic lipid profile in rats fed a high cholesterol diet.
González-Gómez D, Lozano M, Fernández-León MF, Bernalte MJ, Phytother Res 29(10): 1652–1657.
Ayuso MC, Rodríguez AB. 2009. Sweet cherry phytochemicals: Paiva-Martins F, Gordon MH. 2001. Isolation and characterization of
identification and characterization by HPLC-DAD/ESI-MS in six the antioxidant component 3,4-dihydroxyphenylethyl-4-formyl-
sweet-cherry cultivars grown in Valle del Jerte (Spain). J Food 3-formylmethyl-4-hexenoate from olive (Olea europaea) leaves.
Compos Anal 23: 533–539. J Agric Food Chem 49: 4214–4219.
Grodzinska-Zachwieja Z, Kahl W. 1966. Bacteriostatic action of Pereira AP, Ferreira I, Marcelino F, et al. 2007a. Phenolic com-
chicory (Cichorium intybus L.) II. The action of chlorogenic pounds and antimicrobial activity of olive (Olea europaea L.
and isochlorogenic acid. Acta Biol Cracov Bot 9: 87–95. cv. cobrançosa) leaves. Molecules 12: 1153–1162.
Heleno SA, Martins A, Queiroz MJ, Ferreira IC. 2015. Bioactivity Pereira JA, Oliveira I, Sousa A, et al. 2007b. Walnut (Juglans regia
of phenolic acids: metabolites versus parent compounds: a L.) leaves: phenolic compounds, antimicrobial activity and
review. Food Chem 173: 501–513. antioxidant potential of different cultivars. Food Chem Toxicol
Hur SJ, Lim BO, Decker DA, McClements DJ. 2011. In vitro human 45: 2287–2295.
digestion models for food applications. Food Chem 125: Pinelo M, Rubilar M, Jerez M, Sineiro J, Núñez MJ. 2005. Effect of
1–12. solvent, temperature and solvent to solid ratio on the total
Japón-Luján R, Luque de Castro MD. 2008. Liquid–liquid extrac- phenolic content and anti-radical activity of extracts from
tion for the enrichment of edible oils with biophenols from different components of grape pomace. J Agric Food Chem
olive leaf extracts. J Agric Food Chem 56: 2505–2011. 53: 2111–2117.
Karakaya S. 2004. Bioavailability of phenolic compounds. Crit Rev Samaniego C, Troncoso AM, Garcia MC, Quesada JJ, Lopez H,
Food Sci Nutr 44(6): 453–464. Lopez MC. 2007. Different radical scavenging tests in virgin
Kishikawa A, Ashour A, Zhu Q, Yasuda M, Ishikawa H, Shimizu K. olive oil and their relation to the total phenol content. Anal
2015. Multiple biological effects of olive oil by-products such Chim Acta 593: 103–107.
as leaves, stems, flowers, olive milled waste, fruit pulp, and Samet I, Han J, Jlaiel L, Sayadi S, Isoda H. 2014. Olive
seeds of the olive plant on skin. Phytother Res 29(6): (Olea europaea) leaf extract induces apoptosis and
877–886. monocyte/macrophage differentiation in human chronic
Lee JB, Ahn J, Lee J, Kwak HS. 2003. The microencapsulated myelogenus leukemia K562 cells: insight into the underlying
ascorbic acid release in vitro and its effect on iron bioavailabil- mechanism. Oxid Med Cell Longev 2014: 927619.
ity. Arch Pharm Res 26: 874–879. Schieber A, Stintzing F, Carle R. 2001. By-products of plant food
Lee OH, Lee BY. 2010. Antioxidant and antimicrobial activities of processing as a source of functional compounds—recent
individual and combined phenolics in Olea europaea leaf developments. Trends Food Sci Technol 12: 401–413.
extract. Bioresour Technol 101: 3751–3754. Somova LI, Shode FO, Ramnanan P, Nadar A. 2003. Antihyperten-
Ma SC, He ZD, Deng XL, et al. 2001. In vitro evaluation of sive, antiatherosclerotic and antioxidant activity of triterpenoids
secoiridoid glucosides from the fruits of Ligustrum lucidum isolated from Olea europaea, subspecies africana leaves. J
as antiviral agents. Chem Pharm Bull 49: 1471–1473. Ethnopharmacol 84: 299–305.
Meirinhos J, Silva B, Valentão P, et al. 2005. Analysis and quanti- Sudjana AN, D’Orazio C, Ryan V, et al. 2009. Antimicrobial activity
fication of flavonoidic compounds from Portuguese olive of commercial Olea europaea (olive) leaf extract. Int J
(Oleae europeae L.) leaf cultivars. Nat Prod Res 19: 189–195. Antimicrob Agents 33: 461–463.
Micol V, Caturla N, Perez-Fons L, Mas V, Perez L, Estepa A. 2005. The United States Pharmacopeial Convention, Inc. 2000. United
The olive leaf extract exhibits antiviral activity against viral States Pharmacopeia and National Formulary USP 24–NF 19.
haemorrhagic septicaemia rhabdovirus (VHSV). Antiviral Res Rockville, MD.
66: 129–136.
Copyright © 2016 John Wiley & Sons, Ltd. Phytother. Res. (2016)